The shortage of a drug approved just shy of one year ago by the FDA to treat prostate cancer is now in limited supply, concerning some physicians.
Read the full post on Becker's Hospital Review - Healthcare News
The shortage of a drug approved just shy of one year ago by the FDA to treat prostate cancer is now in limited supply, concerning some physicians.
Read the full post on Becker's Hospital Review - Healthcare News